Literature DB >> 20091193

The underlying mechanisms for the 'anti-HBc alone' serological profile.

R A A Pondé1, D D P Cardoso, M O Ferro.   

Abstract

The serological pattern, "anti-HBc alone", characterized by the presence of antibodies against the core antigen of hepatitis B virus (anti-HBc) as the only marker of hepatitis B, is not rare in a diagnostic setting. Depending on the prevalence of HBV infection and the patient group investigated, 1-31% of positive anti-HBc results are isolated positive findings. Anti-HBc alone is frequently observed in intravenous drug addicts, HIV-infected individuals, patients who are coinfected with HBV and hepatitis C virus, and pregnant women. However, it is not clear how this profile should be interpreted. Several studies have shown that anti-HBc alone is not only compatible with acute and resolved HBV infection but also with chronic infection. The reasons for the lack of HBsAg and anti-HBs in anti-HBc-alone individuals are not clear, but several mechanisms and possibilities have been suggested that could explain this phenomenon, some of which are delineated in this article.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20091193     DOI: 10.1007/s00705-009-0559-6

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  22 in total

Review 1.  Isolated anti-HBc: The Relevance of Hepatitis B Core Antibody-A Review of New Issues.

Authors:  Tiffany Wu; Ryan M Kwok; Tram T Tran
Journal:  Am J Gastroenterol       Date:  2017-10-31       Impact factor: 10.864

Review 2.  The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

3.  Responses to hepatitis B vaccine in isolated anti-HBc positive adults.

Authors:  Jun Yao; Wen Ren; Yongdi Chen; Zhenggang Jiang; Lingzhi Shen; Huan Shan; Xuewei Dai; Jing Li; Ying Liu; Yan Qiu; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

4.  Serological pattern of Hepatitis B, C, and HIV infections among immigrants in Sicily: epidemiological aspects and implication on public health.

Authors:  Fabio Tramuto; Walter Mazzucco; Carmelo Massimo Maida; Andrea Affronti; Mario Affronti; Giuseppe Montalto; Francesco Vitale
Journal:  J Community Health       Date:  2012-06

Review 5.  Molecular mechanisms underlying HBsAg negativity in occult HBV infection.

Authors:  R A A Pondé
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-24       Impact factor: 3.267

6.  Predictors of the isolated hepatitis B core antibody pattern in HIV-infected and -uninfected men in the multicenter AIDS cohort study.

Authors:  Mallory D Witt; Roger J Lewis; Gunter Rieg; Eric C Seaberg; Charles R Rinaldo; Chloe L Thio
Journal:  Clin Infect Dis       Date:  2012-10-22       Impact factor: 9.079

7.  Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women.

Authors:  Woottichai Khamduang; Nicole Ngo-Giang-Huong; Catherine Gaudy-Graffin; Gonzague Jourdain; Weerapong Suwankornsakul; Tapnarong Jarupanich; Veeradate Chalermpolprapa; Sirisak Nanta; Noossara Puarattana-Aroonkorn; Sakchai Tonmat; Marc Lallemant; Alain Goudeau; Wasna Sirirungsi
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

8.  Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

Authors:  Luisa Romanò; Claudio Velati; Giuseppe Cambiè; Laura Fomiatti; Claudio Galli; Alessandro Remo Zanetti
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

9.  Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study.

Authors:  Sourav Sen; Shakti Prasad Panda; K Shanmuganandan; Rm Gupta; Ak Praharaj
Journal:  Med J Armed Forces India       Date:  2012-01-18

10.  Low rates of hepatitis B virus screening at the onset of chemotherapy.

Authors:  Jessica P Hwang; Michael J Fisch; Hong Zhang; Michael A Kallen; Mark J Routbort; Lincy S Lal; John M Vierling; Maria E Suarez-Almazor
Journal:  J Oncol Pract       Date:  2012-06-12       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.